Christy S. John

2.5k total citations · 1 hit paper
49 papers, 2.0k citations indexed

About

Christy S. John is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christy S. John has authored 49 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christy S. John's work include Radiopharmaceutical Chemistry and Applications (22 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Receptor Mechanisms and Signaling (14 papers). Christy S. John is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (22 papers), Pharmacological Receptor Mechanisms and Effects (16 papers) and Receptor Mechanisms and Signaling (14 papers). Christy S. John collaborates with scholars based in United States, United Kingdom and South Africa. Christy S. John's co-authors include Bertold J. Vilner, W D Bowen, Terry W. Moody, Wayne D. Bowen, M.R.A. Pillai, D.E. Troutner, Brian C. Geyer, Richard Pazdur, Jason Lo and W. Don Bowen and has published in prestigious journals such as Cancer, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Christy S. John

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer

2022 127 citations Jaleh Fallah, Sundeep Agrawal et al. Clinical Cancer Research profile →

Peers

Christy S. John

RNMI

ONCOL

CMN

Rainer Albert Switzerland

Emiko Kawachi Japan

Christopher J. O’Donnell United States

Thomas W. Ku United States

Jacobus D. M. Herscheid Netherlands

B. Johannsen Germany

J. Oliver McIntyre United States

Bernd Riedl Germany

Manon Carré France

Steven K. Davidsen United States

Rainer Albert Switzerland

Christy S. John

2.2k ×1.9

607 ×1.3

RNMI

705 ×1.6

ONCOL

148 ×0.3

CMN

625 ×2.1

Citations per year, relative to Christy S. John Christy S. John (= 1×) peers Rainer Albert

Countries citing papers authored by Christy S. John

Since Specialization

Citations

This map shows the geographic impact of Christy S. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christy S. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christy S. John more than expected).

Fields of papers citing papers by Christy S. John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christy S. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christy S. John. The network helps show where Christy S. John may publish in the future.

Co-authorship network of co-authors of Christy S. John

This figure shows the co-authorship network connecting the top 25 collaborators of Christy S. John. A scholar is included among the top collaborators of Christy S. John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christy S. John. Christy S. John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fallah, Jaleh, Sundeep Agrawal, Haley Gittleman, et al.. (2022). FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 29(9). 1651–1657. 127 indexed citations breakdown →

Norsworthy, Kelly J., Chia‐Wen Ko, Jee Eun Lee, et al.. (2018). FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia. The Oncologist. 23(9). 1103–1108. 189 indexed citations

Verma, Mukesh, et al.. (2006). Genetic and Epigenetic Biomarkers in Cancer. Molecular Diagnosis & Therapy. 10(1). 1–15. 23 indexed citations

Deharo, Eric, Mark Loyevsky, Christy S. John, et al.. (2000). Aminothiol Multidentate Chelators against Chagas Disease. Experimental Parasitology. 94(3). 198–200. 3 indexed citations

Loyevsky, Mark, Christy S. John, Benjamin F. Dickens, et al.. (1999). Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators. Molecular and Biochemical Parasitology. 101(1-2). 43–59. 48 indexed citations

John, Christy S., Wayne D. Bowen, Susan J. Fisher, et al.. (1999). Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1′-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer. Nuclear Medicine and Biology. 26(4). 377–382. 29 indexed citations

Loyevsky, Mark, et al.. (1999). Plasmodium falciparumandPlasmodium yoelii:Effect of the Iron Chelation Prodrug Dexrazoxane onin VitroCultures. Experimental Parasitology. 91(2). 105–114. 16 indexed citations

John, Christy S., et al.. (1998). Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential σ Receptor Marker for Human Prostate Tumors. Nuclear Medicine and Biology. 25(3). 189–194. 33 indexed citations

Moody, Terry W., Julius Leyton, Edward J. Unsworth, et al.. (1998). (Arg15, Arg21) VIP: Evaluation of Biological Activity and Localization to Breast Cancer Tumors. Peptides. 19(3). 585–592. 39 indexed citations

10.

Zamora, Paul O., Terry W. Moody, & Christy S. John. (1998). Increased binding to sigma sites of N-[1′(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation. Life Sciences. 63(18). 1611–1618. 18 indexed citations

11.

Dence, Carmen S., Christy S. John, W. Don Bowen, & M. J. Welch. (1997). Synthesis and evaluation of [18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging. Nuclear Medicine and Biology. 24(4). 333–340. 37 indexed citations

12.

Loyevsky, Mark, et al.. (1997). Aminothiol multidentate chelators as antimalarials. Biochemical Pharmacology. 54(4). 451–458. 12 indexed citations

13.

John, Christy S., et al.. (1996). Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-Iodophenyl)Ethyl]-N-Methyl-2-(1-Piperidinyl) ethylamine: A high-affinity ligand for imaging sigma receptor positive tumors. Nuclear Medicine and Biology. 23(6). 761–766. 24 indexed citations

14.

Anderson, Carolyn J., Christy S. John, Robert D. Hancock, et al.. (1995). N,N′-Ethylene-di-l-Cysteine (EC) complexes of Ga(III) and In(III): Molecular modeling, thermodynamic stability and in vivo studies. Nuclear Medicine and Biology. 22(2). 165–173. 36 indexed citations

15.

John, Christy S., Wayne D. Bowen, Vijay M. Varma, John G. McAfee, & Terry W. Moody. (1995). Sigma receptors are expressed in human non-small cell lung carcinoma. Life Sciences. 56(26). 2385–2392. 54 indexed citations

16.

John, Christy S., et al.. (1995). Preparation and preliminary evaluation of 4-[211At]astato-N-piperidinoethyl benzamide. Nuclear Medicine and Biology. 22(4). 467–473. 10 indexed citations

17.

Erdi, Alev K., B. W. Wessels, Yusuf E. Erdi, et al.. (1994). Tumor activity confirmation and isodose curve display for patients receiving iodine-131-labeled 16.88 human monoclonal antibody. Cancer. 73(S3). 932–944. 15 indexed citations

18.

John, Christy S., Bertold J. Vilner, & Wayne D. Bowen. (1994). Synthesis and Characterization of [125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide, a New .sigma. Receptor Radiopharmaceutical: High-Affinity Binding to MCF-7 Breast Tumor Cells. Journal of Medicinal Chemistry. 37(12). 1737–1739. 60 indexed citations

19.

John, Christy S., Seigo Kinuya, Nhat Le, et al.. (1993). An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma. Nuclear Medicine and Biology. 20(1). 75–79. 15 indexed citations

20.

John, Christy S., et al.. (1993). Synthesis and biological evaluation of gallium polyaminothiols (PAT). Nuclear Medicine and Biology. 20(2). 217–223. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact